- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Bendamustine – July 2015
Bendamustine; powder for injection 100 mg vial, 1; powder for injection 25 mg vial, 1; Ribomustin®
Last updated
1 November 2015